TAKEDA (Entyvio)

ABOUT THE BRAND

Takeda Pharmaceutical Company Limited, or known in Japan as Takeda Yaku Kōgyō kabushiki gaisha is a Japanese-American multinational pharmaceutical company. The group has partial American and British roots, and is the largest pharmaceutical company in Asia. It is also one of the 20 largest pharmaceutical companies in the world by revenue, and they employ almost 50,000 employees all over the world. The company focuses on providing products that help with metabolic disorders, oncology, neurology, inflammation, and gastroenterology, with oncology being researched and formulated by their independent subsidiary, Takeda Oncology.  

One of the product sin their vast and varied portfolio is Entyvio, with the generic name of vedolizumab. It is used generally to treat ulcerative colitis and Chron’s disease, and it makes use of a monoclonal antibody to target and attach itself to the inflammation-causing antigen found when patients suffer from the aforementioned ailments. This medication is generally used when previous treatments have already failed, and has shown to be quite effective in both clinical studies and real-life cases, leading it to be one of the more highly-recommended medications of its kind. 

Information on Peak Medical Wholesale is provided for informational purposes only and may not cover all precautions, side effects, and other information about any given product. Peak Medical Wholesale cannot guarantee the accuracy of all information here, including but not limited to instructions for use. Peak Medical Wholesale reserves the right to change product prices at any time before billing customer and cannot guarantee all products listed on the website are available at any given time. All brand names and product images on Peak Medical Wholesale belong to their respective owners and Peak Medical Wholesale is in no way affiliated with the manufacturers of these products. Only qualified and suitably-trained medical practitioners should purchase and use medical products.